DoctorsProofNPPES directory · verify at state boards

Pulmonary Disease in Hammonton, NJ

3 verified pulmonary disease doctors in Hammonton.

Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the New Jersey State Board of Medical Examiners

Dr. Kevin Gilmour, DO

Pulmonary Disease

20 yrs NPPES
NPI 1275540106
107 VINE ST, SOUTH JERSEY CHEST DISEASES, Hammonton, NJ 08037(609) 561-7666
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $585.93 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$585.93

Total received

44

Transactions

11

Paying companies

Top paying companies

GlaxoSmithKline, LLC.$192.01
Boehringer Ingelheim Pharmaceuticals, Inc.$62.50
Genzyme Corporation$61.30
Actelion Pharmaceuticals US, Inc.$46.78
Regeneron Healthcare Solutions, Inc.$45.56
United Therapeutics Corporation$43.67

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 75th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Kevin Gilmour do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Albert Belli, DO

Pulmonary Disease

20 yrs NPPES
NPI 1184631012
107 VINE ST, Hammonton, NJ 08037(609) 561-7666
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $397.62 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$397.62

Total received

22

Transactions

8

Paying companies

Top paying companies

Actelion Pharmaceuticals US, Inc.$112.76
Regeneron Healthcare Solutions, Inc.$62.29
AstraZeneca Pharmaceuticals LP$60.63
Philips North America LLC$46.74
GlaxoSmithKline, LLC.$44.49
Genzyme Corporation$28.58

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 71th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Albert Belli do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jack Kanoff, DO

Pulmonary Disease

20 yrs NPPES
NPI 1902813843
107 VINE ST, Hammonton, NJ 08037(609) 561-7666
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $364.71 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$364.71

Total received

24

Transactions

10

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$73.04
Philips North America LLC$67.88
Regeneron Healthcare Solutions, Inc.$50.20
Genzyme Corporation$44.29
GlaxoSmithKline, LLC.$39.44
Actelion Pharmaceuticals US, Inc.$30.17

Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 70th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.

Payments to Jack Kanoff do not imply any wrongdoing. Many are meals, education, or research support.

Pulmonary Disease in Hammonton, NJ — Verified | DoctorsProof | DoctorsProof